JPRN-UMIN000030158已完成未知
Effect of Empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: Multi-Center placebo-controlled Double-Blind Randomized Trial - Effect of Empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: Multi-Center placebo-controlled Double-Blind Randomized Trial -EMBODY trial
ippon Medical School Hospital0 个研究点目标入组 98 人开始时间: 2017年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Type 1 diabetes mellitus 2) Persistent atrial fibrillation 3) Insulin, glucagon-like peptide-1 analogue, or other SGLT2 inhibitors user 4) High dose of sulfonylurea (glimepiride > 2 mg, glibenclamide > 1.25 mg, gliclazide > 40 mg) 5) HbA1c >= 10% 6) History of diabetic ketoacidosis or diabetic coma within 3 months prior to the randomization 7) Renal dysfunction (eGFR < 45 mL/min/1.73m2) 8) Heart failure graded at NYHA functional class IV 9) Pregnancy or possible pregnancy and breast feeding 10) Lack of informed consent 11) Patients judged by the investigator to be ineligible for inclusion in this study 12) Contraindicated for administration of empagliflozin
研究者
相似试验
尚未招募
2 期
Efficacy of Empagliflozin on cardiac function in non- diabetic patients after primary percutaneous angioplasty on left anterior descending coronary arteryacute myocardial infarction.121-09IRCT20200727048226N1Tehran University of Medical Sciences88
进行中（未招募）
1 期
Impact of Empagliflozin on heart in patients with myocardial infarctioMyocardial infarctionEUCTR2016-004591-22-ATMedical University of Graz/Department of Internal Medicine/Division of Endocrinology and Diabetology476
进行中（未招募）
1 期
Effect of Empagliflozin on Cardiac Output in Patients with Acute Heart Failure (EMPA Acute Heart Failure)EUCTR2017-002695-45-DERWTH Aachen University represented by the Rector, himself, represented by the Dean of the Medical Faculty50
进行中（未招募）
1 期
Effects of empagliflozin on cardiac remodeling and myocardial sympathetic nervous system in diabetic patients affected by chronic heart failurediabetes mellitus and heart failureMedDRA version: 20.0Level: LLTClassification code 10011949Term: Decompensation cardiacSystem Organ Class: 100000004849EUCTR2019-002202-43-ITAOU FEDERICO II34
进行中（未招募）
1 期
Effect of Empagliflozin and Semaglutide on the Cardiovascular system and Kidneys in patients with type 2 diabetes – A randomized TrialMedDRA version: 20.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Type 2 Diabetes MellitusEUCTR2019-000781-38-DKAarhus University Hospital120